COMMUNIQUÉS West-GlobeNewswire

Cognition Therapeutics Expands Clinical Expertise on Medical Advisory Board with Addition of Drs. Mary Sano and Philip Scheltens
05/04/2019
Pittsburgh, April 05, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative diseases and [...]
Blissco Products Available for Sale at BC Cannabis Store and Blissco Ships Second Purchase Order to BCLDB
05/04/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, April 05, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
Exclusive Interview: Gabriella’s Kitchen Cements The Foundation Upon Which to Build Its California Cannabis House of Brands -- CFN Media
05/04/2019
SEATTLE, April 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]
TG Therapeutics to Present at the 18th Annual Needham Healthcare Conference
05/04/2019
Presentation scheduled for Tuesday, April 9, 2019, at 4:50PM ET NEW YORK, April 05, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Executive Chairman [...]
NexImmune Management to Present at Upcoming Conferences
05/04/2019
GAITHERSBURG, Md., April 05, 2019 (GLOBE NEWSWIRE) -- NexImmune, an emerging leader in the field of antigen-directed immunotherapy, today announced that Scott Carmer, Neximmune’s Chief Executive Officer, will be [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
05/04/2019
Company announcement – No. 12 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, April 5, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 [...]
Mesoblast to Present at Upcoming Global Life Sciences Conference in London
05/04/2019
NEW YORK and MELBOURNE, Australia, April 05, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced an upcoming corporate [...]
Curetis to Publish its Full-Year 2018 Financial Results on April 11, 2019
05/04/2019
Company to host earnings conference call on same day Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 5, 2019, 08:00 am CET - Curetis N.V. (the " Company " and, together with its subsidiaries, "Curetis"), a [...]
Enzymatica AB:Notice of annual general meeting 2019 in Enzymatica AB (publ)
05/04/2019
Press release 5 April, 2019 Notice of annual general meeting 2019 in Enzymatica AB (publ) The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the “Company”) are hereby invited to attend the annual general [...]
Professor Linda Carpenter joins Nexstim's Scientific Advisory Board
05/04/2019
Press release, Helsinki, 5 April 2019 at 9.00 am (EET) Professor Linda Carpenter joins Nexstim's Scientific Advisory Board Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and [...]
Genmab Announces Submission of Supplemental New Drug Application in Japan for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
05/04/2019
Media Release Copenhagen, Denmark, April 5, 2019 Supplemental new drug application (sNDA) submitted in Japan for daratumumab in combination with lenalidomide and dexamethasone as treatment for patients newly diagnosed [...]
DBV Technologies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares (ADS)
05/04/2019
Montrouge, France, April 5, 2019 DBV Technologies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares, Including in the Form of [...]
DBV Technologies annonce l’exercice de la totalité de l’option de surallocation consentie dans le cadre de son offre globale d’actions ordinaires pouvant prendre la forme d’American Depositary Shares
05/04/2019
Montrouge, France, le 5 avril (07h30 CEST), 2019 DBV Technologies annonce l’exercice de la totalité de l’option de surallocation consentie dans le cadre de son offre globale d’actions ordinaires pouvant prendre la forme [...]
ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
05/04/2019
Amsterdam, The Netherlands – 05 April 2019 Esperite N.V. (Euronext: ESP, “ Esperite ”) announces today a EUR 250,000 private placement of 25 convertible notes with a principal amount of EUR 10,000 each (the “ Notes ”), [...]
Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES
05/04/2019
PRESS RELEASE REGULATED INFORMATION 5 April 2019, 07:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium, 5 April 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
Zealand Pharma announces Emmanuel Dulac as new CEO
05/04/2019
Company announcement – No. 11 / 2019 Zealand Pharma announces Emmanuel Dulac as new CEO Emmanuel Dulac will join Zealand Pharma as new Chief Executive Officer on April 22, 2019. Emmanuel comes from a position as Chief [...]
AnGes Obtains Conditional Approval in Japan for HGF Gene Therapy to Treat Critical Limb Ischemia
05/04/2019
TOKYO, April 05, 2019 (GLOBE NEWSWIRE) -- AnGes, Inc., a biopharmaceutical company focused on developing innovative gene-based medicines for treating serious diseases, announced today that they have obtained conditional [...]
Profound Medical Announces Positive Topline Results from TACT Pivotal Clinical Trial of TULSA-PRO® in Patients with Prostate Cancer
05/04/2019
All Primary Efficacy and Safety Endpoints, and Key Secondary Endpoints Achieved TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
04/04/2019
Company Release no. 07/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 04 April 2019 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]

Pages